Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
UAB 1395 - Randomized Phase II Screening Trial of Enzalutamide/MDV-3100 and LHRH Analogue vs Combined Androgen Deprivation (LHRH Analogue + Bicalutamide) in Metastatic Hormone Sensitive Prostate Cancer
Grant
Overview
Affiliation
Overview
Date/time Interval
September 28, 2019 - August 25, 2021
Awarded By
KARMANOS CANCER CENTER
Total Award Amount
0.00
Direct Costs
0.00
Sponsor Award Id
Affiliation
Contributor
Lakshminarayanan Nandagopal
Principal Investigator
Mollie Deshazo M.D.
Investigator